From April 1, 2024 to May 7, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 4,445,000 shares, representing 1.51% for CNY 30.1 million under the buyback announced on February 6, 2024.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 CNY | +0.21% | +6.03% | -49.14% |
Jun. 27 | Guangdong Hybribio Biotech Co.,Ltd. announces an Equity Buyback for CNY 60 million worth of its shares. | CI |
Jun. 27 | Guangdong Hybribio Biotech Co.,Ltd. authorizes a Buyback Plan. | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.14% | 419M | |
-10.83% | 11.36B | |
-19.13% | 7.17B | |
+26.61% | 5.55B | |
+3.47% | 5.33B | |
-20.49% | 3.65B | |
+6.88% | 2.59B | |
-66.28% | 2.23B | |
-14.18% | 2.2B | |
+29.36% | 2.17B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.